期刊文献+

PHCC合并2型糖尿病患者血清中IGF-1、FPG、AFP的改变及其临床意义 被引量:1

Clinical significance of serum IGF-1,FPG and AFP in PHCC patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨胰岛素样生长因子-1(IGF-1)、空腹血糖(FPG)、甲胎蛋白(AFP)在原发性肝癌(PHCC)合并2型糖尿病患者血清中的改变及其临床意义。方法收集正常人群组、2型糖尿病组、PHCC组和PHCC合并2型糖尿病组人群基本资料及血液样本,检测外周血IGF-1、FPG、AFP水平的变化;并对PHCC合并2型糖尿病组患者治疗前后血清IGF-1、AFP水平变化进行分析。结果与正常人群组、2型糖尿病组及PHCC组相比,PHCC合并2型糖尿病组患者血清IGF-1水平降低,差异有统计学意义(P<0.05),且期别越晚IGF-1水平越低。与正常人群组相比,PHCC组、PHCC合并2型糖尿病组患者血清FPG、AFP水平均升高,差异有统计学意义(P<0.05)。与同期治疗前相比,治疗后PHCC合并2型糖尿病组患者外周血清IGF-1水平升高,AFP水平降低,差异有统计学意义(P<0.05)。结论PHCC患者血清IGF-1水平低于正常人群,PHCC合并2型糖尿病组患者血清IGF-1水平低于正常人群及2型糖尿病组患者,IGF-1可作为2型糖尿病患者肝癌发生的预测指标。 Objective To investigate changes in insulin-like growth factor-1(IGF-1),fasting plasma glucose(FPG),primary hepatocellular carcinoma(PHCC),a-fetoprotein(AFP)in patients with PHCC and type 2 diabetes mellitus(T2DM)and its effect on prognosis.Methods The basic data and blood samples of normal group,T2DM group,PHCC group and PHCC combined with T2DM group were collected to detect the changes of IGF-1,FPG and AFP,and changes of IGF-1 and AFP in serum before and after treatment were analyzed.Results Compared with the normal group,the T2DM group and PHCC group,the level of IGF-1 in the patients with PHCC and T2DM group decreased significantly(P<0.05),and the later the period,the lower the level of IGF-1.Compared with the normal group,the level of FPG and AFP in the PHCC group and PHCC combined with T2DM group decreased significantly(P<0.05),Compared with before the treatment,the level of IGF-1 and AFP in the patients with PHCC and T2DM increased significantly(P<0.05).Conclusion The serum IGF-1 level of the patients with PHCC is lower than that of the normal people,and the serum IGF-1 level of the patients with PHCC and T2DM is lower than that of the normal people and T2DM.IGF-1 can be used as a predictive index for the occurrence of liver cancer in the patients with T2DM.
作者 石光英 杨丽丽 谢敬东 SHI Guangying;YANG Lili;XIE Jingdong(Department of Hepatology,Xinjiang Production and Construction Corps Hospital,Urumqi 830002,China;Department of Medicine,The Second People's Hospital of Wujiaqu City,Xinjiang Wujiaqu 831300,China;Department of infection,Ruijin Hospital,School of medicine,Shanghai Jiaotong University,Shanghai 200025,China)
出处 《新疆医科大学学报》 CAS 2020年第6期749-753,共5页 Journal of Xinjiang Medical University
基金 新疆兵团科技计划项目(2016AD011)。
关键词 胰岛素样生长因子-1 原发性肝癌 2型糖尿病 insulin-like growth factor-1(IGF-1) primary hepatocellular carcinoma(PHCC) type 2 diabetes mellitus(T2DM)
  • 相关文献

参考文献7

二级参考文献30

  • 1段琼红,王志刚,朱桂宝,卢祖洵,施侣元,聂绍发.血清IGF-1、IGFBP-3水平和大肠癌关系的Meta分析[J].中华流行病学杂志,2005,26(2):132-134. 被引量:11
  • 2薛亚梅,李坤,吕杰强.IGF-1对细胞凋亡的抑制调控[J].生命科学,2007,19(1):68-72. 被引量:13
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50. 被引量:63
  • 4赫捷,赵平,陈万青.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.56-59. 被引量:35
  • 5Curado MPEB,Shin HR,Storm H,et al. Cancer Inci- dence in Five Continents,Vol. IX [M] . Lyon: IARC Sci- entific Publication,2008. 1-837. 被引量:1
  • 6Felay L, Burkhard C,Whe|an S,et al. Cheek and Conver- sion Programs for Cancer Registries. IARC Technical Re- port No.42[M]. Lyon : IARC, 2005. 被引量:1
  • 7Bray F,Parkin DM. Evaluation of data quality in the can- cer registry:principles and methods. Part I :comparabili- ty, validity and timeliness [J]. Eur J Cancer, 2009,45 (5).. 747-755. 被引量:1
  • 8Parkin DM,Chen VW,Ferlay J,et al. Comparability and Quality Control in Cancer Registration. |ARC Technical Report No.19[M]. Lyon:|ARC, 1994-. 被引量:1
  • 9Felay J. The IARCcrgTools program[EB/OL], http://www.i- acr.com.fr/iarccrgtoo|s.htm. 被引量:1
  • 10Allemani C,Weir HK,Carrira H,et al. Global surveil- lance of cancer survival 1995-2009 :analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[J]. Lancet,2014, Nov 26.[Epub ahead of print]. 被引量:1

共引文献6275

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部